RE:RE:RE:RE:RE:True? Crop buying out 1933?You got it on a couple of fronts.
Realized revenue will not be reflected on the books until Q3 or Q4 of 2019.
Best case scenario is recreational cannabis as a states-rights issue - adress banking and taxation on a federal level and keep the doors on the marketplace from everybody and anybody wanting to operate.
Mangler85 wrote: near term CataList are clearly hype based as they will need time to roll out to really see the revenues .
So let’s go by your opinion that Republicans take the next election at midterms. Most likely they will federally legalize medical cannabis but they will probably leave recreational to a state-by-state choice.in my opinion the recreational product will not cross state borders and Nevada will Most likely have the highest profit margin’s per gram in the states.
BaitingBateman wrote: Is there anything speculative about a fully legalized recreational marking in NV? So why would a company be valued on a forward-looking basis?
$100mm MC is the equivalent of a 5:1 price to sales value - which, is actually quite healthy.
Financials will not be as impressive as you think. YE (or Q4) will capture the period of time from May through to the end of July. From Brayden's latest interview, they are just now almost hitting a $20mm run-rate. As of October, they are below $5mm / qt.
Q4 will be in the $3.75-4.25mm range, likely on the lower end.
gwizard wrote: I agree, this company is surprisingly quiet. Given the production potential here that is due to come online in a very short while, I cant wrap my head around why this is trading at only a 100 million market cap. Financial will be impressive, no doubt about that, but we need more. Brayden needs to promote the company and he promised to do so during the Reddit AMA. We are about to expand bigtime and yet we trade at this ridiculous price? Isn't the market forward looking? How patient do we need to be? I'm also surprised no one has made a hostile bid for this company at this price, but what the heck do I know.